Wolfgang A G Sauerwein
Overview
Explore the profile of Wolfgang A G Sauerwein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jacobsen V, Jacobsen V, Pan V, Tran L, Vohradsky J, Bonnelykke J, et al.
Phys Med Biol
. 2025 Feb;
70(5).
PMID: 39899981
The clinical advantage of proton therapy, compared to other types of irradiations, lies in its reduced dose to normal tissue. Still, proton therapy faces challenges of normal tissue toxicity and...
2.
Fithroni A, Inoue H, Zhou S, Hakim T, Tada T, Suzuki M, et al.
Cells
. 2025 Jan;
14(1.
PMID: 39791761
Boron (B) neutron capture therapy (BNCT) is a novel non-invasive targeted cancer therapy based on the nuclear capture reaction B (n, alpha) Li that enables the death of cancer cells...
3.
Ciccone L, Franzetti J, Bonora M, Ronchi S, Camarda A, Charalampopoulou A, et al.
Crit Rev Oncol Hematol
. 2024 Aug;
202:104463.
PMID: 39098367
The role of external beam radiotherapy (EBRT) in thyroid cancer (TC) remains contentious due to limited data. Retrospective studies suggest adjuvant EBRT benefits high-risk differentiated thyroid cancer (DTC) and limited-stage...
4.
Lesnikowski Z, Ekholm F, Hosmane N, Kellert M, Matsuura E, Nakamura H, et al.
Cells
. 2024 May;
13(10.
PMID: 38786022
Given the renewed interest in boron neutron capture therapy (BNCT) and the intensified search for improved boron carriers, as well as the difficulties of coherently comparing the carriers described so...
5.
Wittig A, Sauerwein W
Cancer Biother Radiopharm
. 2023 Apr;
38(3):195-200.
PMID: 37023401
Boron neutron capture therapy (BNCT) involves infusion of cancer patients with a tumor-seeking, boron-loaded compound and irradiation by a beam of neutrons, with an energy range of 1 eV-10 keV....
6.
Finger P, Stewart R, Rivard M, Beers R, Kamen J, Lama S, et al.
Brachytherapy
. 2023 Mar;
22(3):416-427.
PMID: 36948988
Purpose: Herein, we study if high-dose-rate (HDR) yttrium-90 (Y) brachytherapy could be utilized by medical physicists, radiation oncologists, and ophthalmic surgeons. Methods And Materials: Yttrium-90 (Y) beta-emitting brachytherapy sources received...
7.
Sauerwein W
Cancer Biother Radiopharm
. 2023 Jan;
38(3):192-194.
PMID: 36602527
Reporting needs uniformity in definitions and terminology. This is crucial in order to be able to compare and aggregate clinical outcomes data across clinical trials. For decades, there is no...
8.
Sauerwein W, Ulcar M
Cancer Biother Radiopharm
. 2022 Dec;
38(3):143-147.
PMID: 36577026
In April 2022, the National Cancer Institute of the United States organized a 3-day seminar, dedicated to boron neutron capture therapy (BNCT). This short article summarizes a presentation from that...
9.
Sauerwein W, Sancey L, Hey-Hawkins E, Kellert M, Panza L, Imperio D, et al.
Life (Basel)
. 2021 Apr;
11(4).
PMID: 33920126
Boron neutron capture therapy (BNCT) has the potential to specifically destroy tumor cells without damaging the tissues infiltrated by the tumor. BNCT is a binary treatment method based on the...
10.
Mishra K, Afshar A, Thariat J, Shih H, Scholey J, Daftari I, et al.
Adv Radiat Oncol
. 2020 Apr;
5(4):682-686.
PMID: 32337386
Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the coronavirus disease (COVID-19) pandemic, hospitals and proton eye therapy facilities must analyze several factors...